Latest papers

Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction.

Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils.

Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K).

Human acidic mammalian chitinase erroneously known as eosinophil chemotactic cytokine is not the ortholog of mouse YM1.

Production of eosinophil chemoattractant activity by ovine gastrointestinal nematodes.

Bovine eotaxin (CCL11)--an unusual member of the eotaxin group--attracts eosinophils in vitro but is not responsible for eosinophilia in the ovary.

Nasal lavage fluid concentrations of eotaxin-1 (CCL11) in naturally occurring allergic rhinitis: relationship to disease activity, nasal luminal eosinophil influx, and plasma protein exudation.

Modulation of murine experimental asthma by Ascaris suum components.

The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.

Therapeutic effect of surfactant protein D in allergic inflammation of mite-sensitized mice.

Selective suppression of leukocyte recruitment in allergic inflammation.

Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26).

Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice.

Influence of age and gender on serum eotaxin concentration in healthy and allergic people.

Activation of humoral immunity and eosinophils in neuromyelitis optica.

Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.

Production of the chemokine eotaxin-1 in osteoarthritis and its role in cartilage degradation.

Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis.

Increased eotaxin in tears of patients wearing contact lenses.

IL-16 activates plasminogen-plasmin system and promotes human eosinophil migration into extracellular matrix via CCR3-chemokine-mediated signaling and by modulating CD4 eosinophil expression.